Tocagen (TOCA)

9.71 +0.34 (3.63%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/8/18 *Est.)

Latest Headlines

UPDATE: H.C. Wainwright Starts Tocagen Inc. (TOCA) at Buy June 11, 2018 7:08 AM - StreetInsider UPDATE: B.Riley/FBR Starts Tocagen Inc. (TOCA) at Buy, 'Breakthrough Data De-risk Phase III Brain Viral Therapy' May 16, 2018 5:35 AM - StreetInsider Tocagen to Present Preclinical Data on Anti-PD-L1 Product Candidate Toca 521 at the 2018 Annual Meeting of The American Society of Gene & Cell Therapy (ASGCT) May 14, 2018 8:00 AM - PR NewsWire Tocagen (TOCA) Reports Q1 Loss of $0.65 May 10, 2018 4:11 PM - StreetInsider Tocagen Reports First Quarter 2018 Financial and Business Results May 10, 2018 4:05 PM - PR NewsWire Tocagen to Report First Quarter 2018 Financial Results on Thursday, May 10 May 3, 2018 4:05 PM - PR NewsWire Tocagen (TOCA) Reports License Agreement with Beijing Apollo Venus Biomedical Technology to Develop & Commercialize Toca 511 & Toca FC in China April 19, 2018 8:07 AM - StreetInsider Tocagen and ApolloBio Enter License Agreement to Develop and Commercialize Toca 511 & Toca FC in the Greater China Region April 19, 2018 8:00 AM - PR NewsWire Tocagen to Present Updated Clinical and Preclinical Data at Three Scientific Conferences April 17, 2018 8:00 AM - PR NewsWire Tocagen (TOCA) Reports Preliminary Toca 6 Phase 1 Data in Patients with Advanced Solid Tumors April 16, 2018 9:05 AM - StreetInsider Tocagen Presents Preliminary Toca 6 Phase 1 Data in Patients with Advanced Solid Tumors at the American Association for Cancer Research (AACR) Annual Meeting 2018 April 16, 2018 9:00 AM - PR NewsWire Full Article List